0001437749-18-004970.txt : 20180319
0001437749-18-004970.hdr.sgml : 20180319
20180319171231
ACCESSION NUMBER: 0001437749-18-004970
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20180319
DATE AS OF CHANGE: 20180319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wrighton-Smith Peter
CENTRAL INDEX KEY: 0001592286
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 18699674
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC
STREET 2: 94C INNOVATION DRIVE
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2018-03-15
0001586049
Oxford Immunotec Global PLC
OXFD
0001592286
Wrighton-Smith Peter
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
1
Chief Executive Officer
Ordinary Shares
2018-03-15
4
A
0
23628
0
A
485296
D
Share Option (Right to Buy)
13.24
2018-03-15
4
A
0
103330
0
A
2028-03-15
Ordinary Shares
103330
103330
D
Options granted under Issuer's 2013 Share Incentive Plan.
Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact for Peter Wrighton-Smith
2018-03-19